Singapore markets closed

Atossa Therapeutics, Inc. (ATOS)

NasdaqCM - NasdaqCM Real-time price. Currency in USD
Add to watchlist
1.5300+0.0100 (+0.66%)
At close: 04:00PM EDT
1.5000 -0.03 (-1.96%)
After hours: 07:17PM EDT
Currency in USD

Valuation measures4

Market cap (intra-day) 191.72M
Enterprise value 103.26M
Trailing P/E N/A
Forward P/E N/A
PEG ratio (5-yr expected) N/A
Price/sales (ttm)N/A
Price/book (mrq)2.11
Enterprise value/revenue N/A
Enterprise value/EBITDA -3.29

Trading information

Stock price history

Beta (5Y monthly) 1.24
52-week change 3155.00%
S&P500 52-week change 322.36%
52-week high 32.3100
52-week low 30.6000
50-day moving average 31.4256
200-day moving average 30.9813

Share statistics

Avg vol (3-month) 31.69M
Avg vol (10-day) 31.73M
Shares outstanding 5125.3M
Implied shares outstanding 6125.3M
Float 8117.48M
% held by insiders 10.06%
% held by institutions 119.21%
Shares short (15 Apr 2024) 412.35M
Short ratio (15 Apr 2024) 43.84
Short % of float (15 Apr 2024) 49.86%
Short % of shares outstanding (15 Apr 2024) 49.86%
Shares short (prior month 15 Mar 2024) 48.48M

Dividends & splits

Forward annual dividend rate 4N/A
Forward annual dividend yield 4N/A
Trailing annual dividend rate 30.00
Trailing annual dividend yield 30.00%
5-year average dividend yield 4N/A
Payout ratio 40.00%
Dividend date 320 Apr 2018
Ex-dividend date 4N/A
Last split factor 21:12
Last split date 320 Apr 2018

Financial highlights

Fiscal year

Fiscal year ends 31 Dec 2023
Most-recent quarter (mrq)31 Dec 2023

Profitability

Profit margin 0.00%
Operating margin (ttm)0.00%

Management effectiveness

Return on assets (ttm)-17.84%
Return on equity (ttm)-28.80%

Income statement

Revenue (ttm)N/A
Revenue per share (ttm)N/A
Quarterly revenue growth (yoy)N/A
Gross profit (ttm)N/A
EBITDA -31.35M
Net income avi to common (ttm)-30.09M
Diluted EPS (ttm)-0.2400
Quarterly earnings growth (yoy)N/A

Balance sheet

Total cash (mrq)88.46M
Total cash per share (mrq)0.71
Total debt (mrq)N/A
Total debt/equity (mrq)N/A
Current ratio (mrq)17.61
Book value per share (mrq)0.73

Cash flow statement

Operating cash flow (ttm)-20.94M
Levered free cash flow (ttm)-11.76M